Literature DB >> 21113944

Quantitative computed tomography is unreliable for measurement of bone mineral density in inadequately chelated adolescent patients with β-thalassemia major: a case-control study.

Deepak Bansal1, S Venkateshwaran, N Khandelwal, R K Marwaha.   

Abstract

BACKGROUND: Utility of quantitative computed tomography (QCT) for assessment of bone mineral density (BMD) in patients with thalassemia is not fully established. Majority of patients with thalassemia in India receive suboptimal iron chelation. There is paucity of data on BMD in this population. Aim was to assess BMD by lumbar QCT in adolescent patients with transfusion dependent β-thalassemia major and compare with controls. PROCEDURE: Study was conducted prospectively, over 15 months. Single energy QCT was performed through first three lumbar vertebrae.
RESULTS: Forty-five patients were enrolled (age: 10-19 years). Thirty-eight normal siblings of patients with thalassemia patients served as controls. Forty percent patients weighed <3rd percentile, 64% were stunted, and 40% had suboptimal sexual maturity scores. Eighteen (40%) patients were on iron chelation with deferiprone. Mean serum ferritin was 2,800 ± 1,473 ng/ml. Mean BMD (mg/cu mm) of cases and controls was 194.5 ± 27.1 and 170.4 ± 28.84, respectively (P = 0.0002). The mean BMD of patients with ferritin <2,000 ng/ml and those with a higher ferritin was 181.2 ± 14.9 and 196.7 ± 25, respectively (P = 0.07). The finding of increased BMD in patients with thalassemia is in stark contrast to published reports. Patients had several risk factors for low BMD, including growth retardation, delayed puberty, and iron overload.
CONCLUSION: Single energy QCT of lumbar vertebrae is not reliable for measurement of BMD in inadequately chelated patients with β-thalassemia major. The deposition of iron in bone tissue may result in increased X-ray attenuation values of trabecular bone.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21113944     DOI: 10.1002/pbc.22912

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Fractures and Low Bone Mineral Density in Patients with Beta Thalassemia Major.

Authors:  Rahul Naithani; Tulika Seth; Nikhil Tandon; Jagdish Chandra; H Pati; Renu Saxena; V P Choudhry
Journal:  Indian J Hematol Blood Transfus       Date:  2017-04-22       Impact factor: 0.900

Review 2.  Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.

Authors:  A D Dede; G Trovas; E Chronopoulos; I K Triantafyllopoulos; I Dontas; N Papaioannou; S Tournis
Journal:  Osteoporos Int       Date:  2016-08-08       Impact factor: 4.507

3.  Zoledronic Acid for Treatment of Low Bone Mineral Density in Patients with Beta Thalassemia Major.

Authors:  Rahul Naithani; Tulika Seth; Nikhil Tandon; Jagdish Chandra; V P Choudhry; H Pati; Renu Saxena
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-27       Impact factor: 0.900

4.  Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.

Authors:  Massimo Scacchi; Leila Danesi; Agnese Cattaneo; Giovanna Sciortino; Raffaella Radin; Alberto Giacinto Ambrogio; Giovanni Vitale; Emanuela D'Angelo; Nadia Mirra; Laura Zanaboni; Marica Arvigo; Mara Boschetti; Diego Ferone; Paolo Marzullo; Marina Baldini; Elena Cassinerio; Maria Domenica Cappellini; Luca Persani; Francesco Cavagnini
Journal:  Endocrine       Date:  2016-01-29       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.